Clinical Trials Directory

Trials / Terminated

TerminatedNCT01587963

High Dose Vitamin C in the Critically Ill Patient

The Efficacy of High Dose Vitamin C in the Critically Ill Patient Population

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.

Detailed description

It has been shown that the stress that occurs during trauma, infection and/or shock depletes many of the body's resources such as Vitamin C (ascorbic acid) which may contribute to further complications. The purpose of this study is to determine the effectiveness of high doses of Vitamin C in critically ill patients.

Conditions

Interventions

TypeNameDescription
DRUGAscorbic Acid66mg/kg/hour of peripheral intravenous Vitamin C infusion for 24 hour duration, maximum total of 200 grams
OTHERRingers Lactate or Normal SalineFluid resuscitation will be given with NS or LR to achieve a same mean urine output of 0.5cc/kg/hour.

Timeline

Start date
2013-02-01
Primary completion
2014-02-01
Completion
2015-04-01
First posted
2012-04-30
Last updated
2017-05-11
Results posted
2017-05-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01587963. Inclusion in this directory is not an endorsement.